Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Genetically modified serotype 5/3 adenovirus coding for granulocyte-macrophage colony-stimulating factor

EU orphan designation number: EU/3/13/1145   
Active ingredient: Genetically modified serotype 5/3 adenovirus coding for granulocyte-macrophage colony-stimulating factor
Indication: Treatment of soft tissue sarcoma
Sponsor: Oncos Therapeutics Oy
Saukonpaadenranta 2, FI-00180 Helsinki, Suomi

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
25/06/2013 Centralised Orphan - Designation EMA/OD/041/13 (2013)3966 of 19/06/2013